Ladislav Habala

{(1<i>R</i>,2<i>R</i>,4<i>R</i>)-4-Methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): A Novel Enantiomerically Pure Oxaliplatin Derivative Showing Improved Anticancer Activity in Vivo

S.A. Abramkin, Ute Jungwirth, Seied M. Valiahdi et al. · Journal of Medicinal Chemistry · 2010 · 55 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Novel Analogue +14

Analysis of anticancer platinum(II)‐complexes by microemulsion electrokinetic chromatography: Separation of diastereomers and estimation of octanol‐water partition coefficients

Christina Rappel, M. Galanski, Afshin Yasemi et al. · Electrophoresis · 2005 · 55 citations

Synthesis and structure-activity relationships of mono- and dialkyl-substituted oxaliplatin derivatives

Ladislav Habala, M. Galanski, Afshin Yasemi et al. · European Journal of Medicinal Chemistry · 2005 · 46 citations

Medicinal Chemistry, Derivative (Chemistry), Natural Sciences +8

Antimicrobial Activity and Urease Inhibition of Schiff Bases Derived from Isoniazid and Fluorinated Benzaldehydes and of Their Copper(II) Complexes

Ladislav Habala, Samuel Varényi, Andrea Bilková et al. · Molecules · 2016 · 39 citations · Full text

REVIEW: metal complexes as urease inhibitors

Ladislav Habala, Ferdinand Devı́nsky, Alexander Egger · Journal of Coordination Chemistry · 2018 · 38 citations

Inorganic Chemistry, Medicinal Chemistry, Urease Inhibition +15